Pneumonia: Overview and Epidemiology

R. G. Wunderink*, G. M. Mutlu

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Pneumonia is the infection of the distal lower respiratory tract, principally the alveolar space, including the small bronchi and bronchioles. Pneumonia results from the proliferation of microorganisms at these sites in combination with the host response to the presence of microorganisms. A variety of pneumonia syndromes can be defined based on microbial etiology, underlying host defenses, clinical presentation, and site of acquisition. Because of the non-specific nature of the signs and symptoms, the diagnosis of pneumonia rests disproportionately on the presence of an infiltrate on chest radiograph. The frequent lack of a microbiologic diagnosis and the non-specificity of signs, symptoms, and radiographic infiltrates leads to frequent consideration of pneumonia in the differential diagnosis of many other pulmonary diseases. The etiologic spectrum of all types of pneumonia always includes the common community-acquired pathogens, with the spectrum broadening in response to either increasing immunocompromise or greater exposure to broad-spectrum antibiotics. While new or previously unrecognized pathogens can play a role in management decisions, the major issue in pneumonia is the appearance of antibiotic resistant strains of known common bacterial pathogens. Lack of even minimally effective agents is more the issue for nonbacterial pneumonias. Immunomodulation, in the form of less immunosuppressive cancer and transplant chemotherapy, immunization, or specific immunomodulatory drugs holds some hope for improving pneumonia outcome in the future.

Original languageEnglish (US)
Title of host publicationEncyclopedia of Respiratory Medicine, Four-Volume Set
PublisherElsevier Inc
Pages402-410
Number of pages9
ISBN (Print)9780123708793
DOIs
StatePublished - Jan 1 2006

Keywords

  • Antiviral agents
  • Atelectasis
  • Bronchiectasis
  • Bronchiolitis
  • Bronchitis
  • Coagulation cascade
  • Colony stimulating factors
  • Defensins
  • Drug-induced pulmonary disease
  • For pneumonia
  • Granulomatosis: wegener's disease
  • Human immunodeficiency virus
  • Immunoglobulins
  • Immunosuppresant therapy
  • Interstitial lung disease: bronchiolitis obliterans organizing pneumonia and cryptogenic organizing pneumonia
  • Interstitial lung disease: hypersensitivity pneumonitis
  • Laryngitis and pharyngitis
  • Leukocytes
  • Lung abscess
  • Macrophages
  • Malignant: bronchogenic carcinoma
  • Malignant: chemotherapeutic agents
  • Mechanical: ventilator-associated pneumonia
  • Pleural effusion: parapneumonic effusion and empyema
  • Pneumonia pathogens: bacterial
  • Pneumonia pathogens: fungal
  • Pneumonia pathogens: mycobacterial
  • Pneumonia: atypical
  • Pneumonia: bacterial
  • Pneumonia: community-acquired
  • Pneumonia: fungal
  • Pneumonia: mycobacterial
  • Pneumonia: nosocomial
  • Pneumonia: parasitic
  • Pneumonia: viral
  • Pneumonias in the immunocompromised host
  • Protein C and protein S
  • Pulmonary thromboembolism: pulmonary emboli
  • Radiation-induced pulmonary disease
  • Ranulocytic: neutrophils
  • Respiratory viruses
  • Systemic disease: diffuse alveolar hemorrhage and Goodpasture's syndrome
  • Systemic disease: eosinophilic lung disease
  • Transplantation
  • Tumors
  • Tumors
  • Upper respiratory tract infection
  • Vaccinations: bacterial
  • Vaccinations: viral
  • Vasculitis: overview
  • Ventilation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Pneumonia: Overview and Epidemiology'. Together they form a unique fingerprint.

Cite this